Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Gheorghe-Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaita, Isabelle van Gelder, Bulent Gorenek, Juan Carlos Kaski, Keld Kjeldsen, Gregory Y H Lip, Bela Merkely, Ken Okumura, Jonathan P Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan L Tamargo, Christian WolpertESC Scientific Document Group

Research output: Contribution to journalReview articlepeer-review

57 Citations (Scopus)
Original languageEnglish
Issue number5
Pages (from-to)731-732an
Number of pages2
Publication statusPublished - 1 May 2018

Bibliographical note

A correction has been published:
EP Europace, Volume 20, Issue 5, 1 May 2018, Pages 738,


  • Antiarrhythmic drugs
  • Arrhythmias
  • Atrial fibrillation
  • Bradycardia
  • EHRA consensus document
  • Extrasystoles
  • Pre-excitation
  • Proarrhythmias
  • Sudden cardiac death
  • Supraventricular arrhythmias
  • Ventricular tachycardia

Cite this